Benzensulfonamider
Filtrerede søgeresultater
NXT629, MedChemExpress
MedChemExpress NXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively. NXT629 has potent anti-tumor activity and inhibits experimental metastasis of cancer cell in animal models.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | NXT629 |
|---|---|
| Formel vægt | 609.78 |
| Opløselighedsinformation | DMSO : 125 mg/mL (204.99 mM; Need ultrasonic) |
| Procent renhed | 99.2% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 609.78 |
| CAS | 1454925-59-7 |
| Holdbarhed | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC=CC=C1)(NC2=CC=C(C3=CC=C(CCCC(N4CC)=NN(CC5=CC=C(C(C)(C)C)C=C5)C4=O)C=C3)N=C2)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C35H39N5O3S |
| Til brug med (applikation) | Cancer-programmed cell death |
Orexin 2 Receptor Agonist, MedChemExpress
MedChemExpress Orexin 2 Receptor Agonist is a potent (EC50 on OX2R is 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio is 70) agonist.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Orexin 2 Receptor Agonist |
|---|---|
| Formel vægt | 586.7 |
| Opløselighedsinformation | DMSO : ≥ 32 mg/mL (54.54 mM) |
| Procent renhed | 99.75% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 586.7 |
| CAS | 1796565-52-0 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=CC=CC(C)=C1)NCCNC2=CC(NS(C3=C(OC)C=CC(C4=CC(C(N(C)C)=O)=CC=C4)=C3)(=O)=O)=CC=C2 |
| Renhedsgrad noter | Research |
| Molekylær formel | C32H34N4O5S |
| Til brug med (applikation) | Neuroscience-Neuromodulation |
LX2343, MedChemExpress
MedChemExpress LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM. LX2343 acts as a non-ATP competitive PI3K inhibitor with an IC50 of 15.99±3.23 μM. LX2343 stimulates autophagy in its promotion of Aβ clearance.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | LX2343 |
|---|---|
| Formel vægt | 474.91 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (210.57 mM) |
| Procent renhed | 99.74% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 474.91 |
| CAS | 333745-53-2 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(NC1=CC=C(OCO2)C2=C1)CN(C3=CC(Cl)=CC=C3OC)S(=O)(C4=CC=CC=C4)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C22H19ClN2O6S |
| Til brug med (applikation) | Neuroscience-Neurodegeneration |
Acetohexamide, MedChemExpress
MedChemExpress Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2; stimulate the pancreas to secrete insulin.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Acetohexamide |
|---|---|
| Formel vægt | 324.4 |
| Opløselighedsinformation | DMSO : 25 mg/mL (77.07 mM; Need ultrasonic) |
| Procent renhed | 99.39% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 324.4 |
| CAS | 968-81-0 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC=C(C(C)=O)C=C1)(NC(NC2CCCCC2)=O)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C15H20N2O4S |
| Til brug med (applikation) | Cancer-programmed cell death |
L755507, MedChemExpress
MedChemExpress L755507 is a potent, selective agonist of β3-AR with an IC50 of 35 nM. L755507 enhances the homology-directed repair (HDR)-mediated genome editing in CRISPR/Cas9 nickase system.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
PKR-IN-2, MedChemExpress
MedChemExpress PKR-IN-2 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160. PKR-IN-2 can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | PKR-IN-2 |
|---|---|
| Formel vægt | 468.57 |
| Opløselighedsinformation | DMSO : 50 mg/mL (106.71 mM; Need ultrasonic) |
| Procent renhed | 95.14% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 468.57 |
| CAS | 1628428-01-2 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | N1C2C(=C(S(NC3=CC=C(C(N4CCC(O)(CC(C)C)CC4)=O)C=C3)(=O)=O)C=CC=2)N=CC=1 |
| Renhedsgrad noter | Research |
| Molekylær formel | C24H28N4O4S |
| Til brug med (applikation) | Cancer-Kinase/protease |
Hydroxyhexamide, MedChemExpress
MedChemExpress Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agents.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Hydroxyhexamide |
|---|---|
| Formel vægt | 326.41 |
| Opløselighedsinformation | DMSO : ≥ 300 mg/mL (919.09 mM) |
| Procent renhed | 99.68% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 326.41 |
| CAS | 3168-01-2 |
| Synonym | (±)-Hydroxyhexamid |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC=C(C(O)C)C=C1)(NC(NC2CCCCC2)=O)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C15H22N2O4S |
| Til brug med (applikation) | COVID-19-immunoregulation |
Etebenecid, MedChemExpress
MedChemExpress Etebenecid is a uricosuric agents, lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys, also inhibits penicillin tubular secretion.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sulfamethoxypyridazine, MedChemExpress
MedChemExpress Sulfamethoxypyridazine is a long-acting sulfonamide antibiotic, for treatment of Dermatitis herpetiformis.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
SU11274, MedChemExpress
MedChemExpress SU11274 is a selective Met inhibitor with IC50 of 10 nM, but has no effects on PGDFRβ, EGFR or Tie2.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | SU11274 |
|---|---|
| Formel vægt | 568.09 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (176.03 mM) |
| Procent renhed | 98.19% |
| Fysisk form | Solid |
| Farve | Orange |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 568.09 |
| CAS | 658084-23-2 |
| Synonym | PKI-SU11274 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC2=C(C=C1)NC(/C2=C/C3=C(C(C(N4CCN(CC4)C)=O)=C(N3)C)C)=O)(N(C)C5=CC=CC(Cl)=C5)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C28H30ClN5O4S |
| Til brug med (applikation) | Cancer-Kinase/protease |
TG101209, MedChemExpress
MedChemExpress TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, appr 30-fold selective for JAK2 than JAK3, and sensitive to JAK2V617F and MPLW515L/K mutations.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | TG101209 |
|---|---|
| Formel vægt | 509.67 |
| Opløselighedsinformation | DMSO : ≥ 50 mg/mL (98.10 mM) |
| Procent renhed | 98.81% |
| Fysisk form | Solid |
| Farve | Gray |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 509.67 |
| CAS | 936091-14-4 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC=CC(NC2=NC(NC3=CC=C(C=C3)N4CCN(CC4)C)=NC=C2C)=C1)(NC(C)(C)C)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C26H35N7O2S |
| Til brug med (applikation) | Cancer-Kinase/protease |
Veralipride, MedChemExpress
MedChemExpress Veralipride is a D2 receptor antagonist. It is an alternative antidopaminergic treatment for menopausal symptoms.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Veralipride |
|---|---|
| Formel vægt | 383.46 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (260.78 mM) |
| Procent renhed | 99.57% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 383.46 |
| CAS | 66644-81-3 |
| Synonym | (±)-Veralipride LIR166 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(NCC1N(CC=C)CCC1)C2=CC(S(=O)(N)=O)=CC(OC)=C2OC |
| Renhedsgrad noter | Research |
| Molekylær formel | C17H25N3O5S |
| Til brug med (applikation) | Neuroscience-Neurodegeneration |
PF-06471553, MedChemExpress
MedChemExpress PF-06471553 is a potent, selective and orally available monoacylglycerol acyltransferase 3 (MGAT3) inhibitor, with an IC50 of 92 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | PF-06471553 |
|---|---|
| Formel vægt | 467.54 |
| Opløselighedsinformation | DMSO : ≥ 150 mg/mL (320.83 mM) |
| Procent renhed | 98.18% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 467.54 |
| CAS | 1808094-07-6 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC2=C(CN(C(CC3=CC=CC(OC)=C3)=O)C2)C=C1)(NC4=NN(C5CCC5)N=C4)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C23H25N5O4S |
| Til brug med (applikation) | Metabolism-sugar/lipid metabolism |
AZD2098, MedChemExpress
MedChemExpress AZD2098 is a potent and selective CC-chemokine receptor 4 (CCR4) inhibitor with pIC50s of 7.8, 8.0, 8.0 and 7.6 for human, rat, mouse and dog respectively, used for asthma research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | AZD2098 |
|---|---|
| Formel vægt | 334.18 |
| Opløselighedsinformation | DMSO : 100 mg/mL (299.24 mM; Need ultrasonic) |
| Procent renhed | 99.86% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 334.18 |
| CAS | 566203-88-1 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC=CC(Cl)=C1Cl)(NC2=NC=CN=C2OC)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C11H9Cl2N3O3S |
| Til brug med (applikation) | COVID-19-immunoregulation |
HMN-176, MedChemExpress
MedChemExpress HMN-176 is a stilbene derivative which inhibits mitosis, interfering with polo-like kinase-1 (plk1), without significant effect on tubulin polymerization.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | HMN-176 |
|---|---|
| Formel vægt | 382.43 |
| Opløselighedsinformation | DMSO : ≥ 30 mg/mL (78.45 mM) |
| Procent renhed | 98.54% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 382.43 |
| CAS | 173529-10-7 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=S(C1=CC=C(OC)C=C1)(NC2=CC=CC=C2/C=C/C3=CC=N(C=C3)=O)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C20H18N2O4S |
| Til brug med (applikation) | Cancer-Kinase/protease |